✉news BusinessStartups first seen 12 h ago, last 1 h ago, peak #2
Novartis signs $7.8 billion drug deal with Chinese startup
Novartis has agreed a deal worth $7.8 billion with a Chinese biotech startup, one of the largest licensing arrangements between a major Western pharmaceutical company and a Chinese drug developer. The agreement underscores growing interest among global drugmakers in China's pipeline of innovative medicines, though details of the specific drug and partner remain limited in early reports.
Why now: Major pharmaceutical deal announcements attract attention because of their size and implications for the global drug development market.
Evidence
API: https://socialmediatrends-api.osmike.com/v1/trends/756333